Indeed, ALDH activity has been associated for a long time with normal SC and CSC resistance to oxazaphosphorines such as cyclophosphamide [23, 25, 51–53], a drug commonly used during NB patient therapy. The gene discussed is LDHA; the disease is neuroblastoma.